BIO-TECHNE Corp - COMMON STOCK (TECH)

Historical Holders from Q3 2014 to Q3 2025

Symbol
TECH on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
152,309,909
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
158,863,082
Holdings value
$8,836,579,390
% of all portfolios
0.012%
Number of holders
562
Number of buys
302
Number of sells
-251
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-TECHNE Corp - COMMON STOCK (TECH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $566,544,556 11,011,556 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -56.7% $186,406,005 -$305,816,579 3,350,818 -62.1% T. Rowe Price Associates, Inc. 30 Sep 2025

Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 158,863,082 $8,836,579,390 +$43,753,734 $55.63 562
2025 Q2 158,628,992 $8,162,083,726 -$121,661,613 $51.45 549
2025 Q1 160,482,754 $9,405,648,682 +$179,026,718 $58.63 570
2024 Q4 156,683,809 $11,287,230,171 +$66,773,071 $72.03 570
2024 Q3 154,600,456 $12,351,604,330 +$7,433,196 $79.93 556
2024 Q2 155,869,664 $11,167,617,679 -$177,733,977 $71.65 567
2024 Q1 158,523,717 $11,156,213,905 +$202,103,671 $70.39 546
2023 Q4 155,453,274 $11,990,770,023 +$252,157,462 $77.16 525
2023 Q3 152,193,816 $10,358,362,931 +$40,449,398 $68.07 522
2023 Q2 151,139,522 $12,331,718,195 +$212,796,041 $81.63 521
2023 Q1 148,715,946 $11,031,044,107 -$125,004,989 $74.19 542
2022 Q4 150,382,048 $12,465,020,754 +$9,251,047,940 $82.88 536
2022 Q3 38,142,242 $10,837,756,102 +$194,266,932 $284 520
2022 Q2 37,209,172 $12,897,621,890 -$179,595,754 $346.64 534
2022 Q1 37,711,486 $16,331,488,594 +$324,651,170 $433.04 546
2021 Q4 36,855,059 $19,055,177,448 -$21,586,911 $517.34 560
2021 Q3 36,736,696 $17,797,604,388 +$72,229,932 $484.57 556
2021 Q2 36,589,162 $16,468,259,256 +$203,566,288 $450.26 504
2021 Q1 36,496,866 $13,940,028,921 +$172,769,577 $381.93 460
2020 Q4 36,189,306 $11,493,926,712 -$16,778,721 $317.55 426
2020 Q3 36,254,970 $8,982,485,029 -$42,929,390 $247.73 409
2020 Q2 36,379,136 $9,604,991,764 -$81,539,071 $264.07 384
2020 Q1 36,823,671 $6,987,799,245 +$119,012,127 $189.62 357
2019 Q4 35,776,726 $7,852,981,745 -$46,029,404 $219.51 366
2019 Q3 35,990,901 $7,043,547,397 +$117,132,644 $195.67 333
2019 Q2 35,416,061 $7,383,307,878 +$61,945,595 $208.49 362
2019 Q1 35,546,314 $7,057,725,860 +$61,379,403 $198.55 347
2018 Q4 35,371,213 $5,119,061,152 -$122,869,763 $144.72 316
2018 Q3 35,826,309 $7,311,255,210 +$15,680,998 $204.11 335
2018 Q2 35,998,975 $5,325,911,858 +$35,737,877 $147.95 333
2018 Q1 35,891,582 $5,420,812,522 -$28,478,791 $151.04 325
2017 Q4 36,357,570 $4,710,259,737 -$46,673,008 $129.55 288
2017 Q3 36,860,326 $4,455,237,647 -$52,528,460 $120.89 282
2017 Q2 37,300,606 $4,382,632,640 +$214,841,252 $117.5 272
2017 Q1 36,529,302 $3,713,044,239 +$392,401,939 $101.65 265
2016 Q4 35,943,908 $3,695,994,947 +$12,675,458 $102.83 270
2016 Q3 35,799,364 $3,917,777,202 -$132,633,733 $109.5 279
2016 Q2 37,060,472 $4,178,830,306 -$54,302,334 $112.77 278
2016 Q1 37,564,549 $3,550,310,945 +$20,269,808 $94.52 251
2015 Q4 37,359,133 $3,362,530,330 +$85,876,184 $90 258
2015 Q3 36,302,435 $3,356,422,402 -$28,590,696 $92.46 245
2015 Q2 36,725,188 $3,616,194,794 +$4,045,129 $98.47 238
2015 Q1 36,495,519 $3,659,215,883 +$67,728,039 $100.29 243
2014 Q4 36,050,484 $3,331,456,988 +$2,869,117,238 $92.4 252
2014 Q3 4,950,723 $463,140,000 +$463,140,000 $93.55 24